- CA$30.04m
- CA$114.25m
Annual income statement for Resverlogix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 16 | 12.7 | 6.2 | 4.62 | 5.06 |
| Operating Profit | -16 | -12.7 | -6.2 | -4.62 | -5.06 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -24.8 | -3.59 | -16.7 | -7.62 | -7.76 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -24.8 | -3.61 | -16.7 | -7.63 | -7.77 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -24.8 | -3.61 | -16.7 | -7.63 | -7.77 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -24.8 | -3.61 | -16.7 | -7.63 | -7.77 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.103 | -0.011 | -0.06 | -0.028 | -0.027 |